Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 months.


Clinical Trial Description

The study takes place at one site (Henri Laborit Hospital, Poitiers, France) and is comparative, randomized and controlled. There are 2 groups : one group is receiving sessions of active tDCS (active group) whereas the second group is receiving sham (placebo) sessions (control group). Patients are randomized either in the active group or in the control group with a 1:1 ratio. An unblinded investigator is responsible of the stimulation part and could not evaluate the patients. The other investigators are blinded and could evaluate the patients. The study is going to evaluate the effect produces by stimulations in the two groups. In the placebo group, after the intensity has reached its maximal intensity (the same as in the active group), the stimulation is stopped after few seconds (30 seconds in mostly studies). This process allow patients in the placebo group to feel the same sensations as patients in the active group (indeed, tingles and itches are felt only during the first few seconds of stimulation). The poor duration of stimulation do not produces clinical effect. The study begins after a withdrawal period of 7 days +/- 3 days with 10 stimulations of 2 mA during 20 minutes from Monday to Friday during 2 weeks. Following these stimulation sessions, the patient will have 5 follow-up visits on site with an investigator and 2 phone follow-up. Visits: - Pre-inclusion visit - V0 visit (inclusion visit): takes place at the earliest 48 hours after stopping benzodiazepines used in the withdrawal period. - Treatment (weeks 0 and 1): 5 days of treatment per week during 2 weeks 2 arms : sham (placebo, 10 stimulations) vs active (10 stimulations of 2 mA) - Visit 1 (Week 4) : short nurse consultation - Visit 2 (Week 6) : short medical consultation - Visit 3 (Week 10) : short medical consultation - Visit 4 (Week 14) : long medical consultation - Visit 5 (Week 18) : nurse phone follow-up - Visit 6 (Week 22) : nurse phone follow-up - Visit 7 (Week 26) : long medical consultation ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03287154
Study type Interventional
Source Centre Hospitalier Henri Laborit
Contact Nematollah Jaafari, Professor
Phone 0033 5 16 52 61 18
Email nemat.jaafari@ch-poitiers.fr
Status Recruiting
Phase N/A
Start date February 8, 2017
Completion date November 2024

See also
  Status Clinical Trial Phase
Completed NCT02911077 - Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Completed NCT00713492 - Computer-Assisted Self-Administration of Ethanol Phase 1
Completed NCT00001673 - Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) N/A
Enrolling by invitation NCT06235632 - Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers N/A
Completed NCT00227916 - Motivational Interviews for Incarcerated Teens - 1 N/A
Completed NCT01671501 - Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients N/A
Completed NCT00575679 - Behavior and Driving Safety Study N/A
Completed NCT00568958 - Naltrexone for Heavy Drinking in Young Adults Phase 4
Completed NCT00183170 - Residual Effects of Intoxication on Student Performance Phase 2
Completed NCT03001024 - WayToServe Español: Online Responsible Beverage Service Training for Spanish-Speaking Servers N/A
Completed NCT01270217 - Behavior and Driving Safety Study II N/A
Completed NCT03956238 - Alcohol Myopia, Objectification, and Sexual Assault N/A
Completed NCT02449772 - Emergency Department (ED) Triage of Alcohol Abuse N/A
Available NCT00457548 - Phone Intervention for Alcohol (ETOH) Use in Emergency Department Motor Vehicle Crash (ED MVC) Patients N/A